BERKELEY HEIGHTS, N.J., March 29, 2011 /PRNewswire/ —
Promidian, a management consulting firm focused on the
pharmaceutical and biotechnology industries, today announced
top-line survey findings about the increasing interest in the
patient-centered medical home (PCMH), a patient-centric
delivery-of-care model that is rapidly gaining nationwide attention
for its potential to improve quality and access to health
care—while reducing costs.
The Promidian PCMH survey was completed in March 2011 and
included a nationwide mix of 181 stakeholders, including
physicians, medical directors, nurses, and administrators and
executives from medical group practices, health plans,
pharmaceutical companies, and employer groups. The survey found
that
- Patient engagement in care, access to care, and a team approach
to care are viewed as the most important components of a PCMH; - Priority disease states highlighted by PCMHs include diabetes,
cardiovascular disease, asthma, obesity, and stroke; - Medication adherence is viewed as extremely important to the
success of a PCMH, and PCMHs are considering and evaluating a
number of tactics to improve medication adherence; - The vast majority of PCMH representatives are interested in
receiving targeted resources to help achieve or maintain
accreditation (eg, programs, tools, and training).
“Our survey identified a number of key priorities and challenges
for PCMHs, as well as highlighted opportunities for pharmaceutical
companies to positively influence and support the evolution of this
innovative care delivery model,” said Kevin Barnett, Executive Vice
President and Managing Director for Promidian.
The complete results of the survey will be available at the
Promidian exhibit booth at the Patient-Centered Primary Care
Collaborative (PCPCC) Conference on March 29-31, at the Ronald
Reagan Building, International Trade Center in Washington,
DC.
‘/>”/>
